Trial Profile
An Open-label, Single Dose, Randomized, Three-way Cross-over Study to Evaluate the Effect of Food on the Pharmacokinetics of Solifenacin and Tamsulosin Administered as Combination Tablet EC905 in Young, Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2014
Price :
$35
*
At a glance
- Drugs Solifenacin/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors Astellas Pharma BV; Astellas Pharma Europe Ltd
- 09 Oct 2013 New trial record